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Doug Fine (2013) states in Too High to Fail: Cannabis and 
the New Green Economic Revolution that to fully understand 
marijuana prohibition and legalization, one needs to approach 
it sociologically as well as scientifi cally. To gain a better 
understanding of the subject, I conducted an extensive 
literature review that included Fine (2013); Room, Fischer, 
Hall, Lenton, and Reuter (2010), Cannabis Policy: Moving 
Beyond Stalemate; Earleywine (2002), Understanding 
Marijuana: A New Look at the Scientifi c Evidence; and Clark 
and Merlin (2013), Cannabis: Evolution and Ethnobotany.
Historically, the cannabis plant has been used to support the 
economy and heal the sick. However, in recent years it has been 
used as a weapon to incarcerate and fi ne millions of farmers, 
caretakers, ill people, and recreational users (Fine, 2013; Room, et 
al., 2010). Although the outlawed status of cannabis has stymied 
its potential for experimentation, research on two of the plant’s 
cannabinoids, tetrahydrocannabinol and cannabidiol, has shown 
that they have potential use as medical treatments that greatly 
improve the quality of life for humans and other mammals that 
suffer from both chronic and acute conditions such as spasticity, 
chronic nausea and vomiting, and chronic pain due to cancer (Clark 
& Merlin, 2013; Earleywine, 2002). Because of this, cannabis and 
cannabinoid scientists argue that cannabis should be declassifi ed as 
a Schedule I drug and legalized (Clark & Merlin, 2013).
Both marijuana activists and the Global Commission on Drug 
Policy claim that legalization of cannabis would increase the 
quality of life and decrease physical pain for millions of citizens, 
as well as bring millions of dollars into the U.S. economy 
(Fine, 2013). Cannabis has medical value beyond its isolated 
cannabinoids, and the Global Commission on Drug Policy admits 
that the war on drugs has failed (Clark & Merlin, 2013; Fine, 2013). 
Law Enforcement Against Prohibition, a national activist group 
consisting of former antidrug law enforcement agents who seek 
to end marijuana prohibition, issued the following statement via 
former offi cer Chad Padgett: “Marijuana prohibition does not work 
and never has. . . . We can prioritize violent crime . . . [or] we can 
continue to prioritize a war on drugs which has not succeeded by 
any measure” (Clark & Merlin, 2013).
Research advisor Harold Pinnick writes: “Whitney has generated 
a thoughtful overview of the status of marijuana in the United 
States. This includes not only the current status, but also the 
historical background of this interesting topic. This work should 
help stimulate future discussions about this important commodity.”
 STEM
Twenty-three states and the District of Columbia allow use of 
marijuana for medical purposes. In 11 other states, lawmakers 
















































MEDICAL MARIJUANA IN THE U.S.
Comprehensive medical marijuana program
CBD products only
None
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